Ceribell Stock

ceribell.comHealthcareFounded: 2014Funding to Date: $103.84MM

Ceribell is the developer of a highly innovative electroencephalography (EEG) device, designed to make the diagnosis of neurological patients drastically more efficient.

Register for Details

For more details on financing and valuation for Ceribell, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Ceribell.

Register Today

Team

Management Team

Raymond Woo Ph.D
Chief Technology Officer
Josef Parvizi MD
Co-Founder, Chief Medical Adviser & Chairman
Chris Chafe
Co-Founder
Jane Chao Ph.D
Chief Executive Officer & Co-Founder

Board Members

Josef Parvizi MD

Other companies like Ceribell in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

Ceribell, Inc. announced today it has closed a $50 million financing round led by new investor Ally Bridge Group, with participation from existing shareholders. The financing was structured as an extension of the company's previously announced Series C financing.